This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: BA, EW, ZNGA, JCP, BBY

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Adobe Systems (ADBE) downgraded at Jefferies to Hold from Buy, Jefferies said. $32 price target. Too much change to navigate comfortably.

Best Buy (BBY) upgraded at Citigroup to Neutral from Sell, Citigroup said. $21 price target. More balanced risk/reward after 35% pullback.

Beneficial Mutual Bancorp (BNCL) downgraded to hold at TheStreet Ratings.

Clean Energy Fuels (CLNE) downgraded to sell at TheStreet Ratings.

Human Genome (HGSI) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Benlysta likely faces an uphill battle to gain adoption for doctors treating lupus.

Immunogen (IMGN) rated new Hold at Cantor. $15 price target. Stock is already factoring in commercial revenue expected from Roche deal.

Nike (NKE) upgraded at McAdams from Sell to Hold, McAdams Wright Ragen said. Stock has pulled back to a fair value.

STOCK COMMENTS / EPS CHANGES

Boeing (BA) estimates lowered at UBS through 2013, UBS said. Gauging MAX impact on BCA margins. Neutral rating and $72 price target.

Crane (CR) estimates, target reduced at Keybanc. CR estimates were cut through 2013, Keybanc said. Strong dollar and lower commecial demand could hurt near-term results. Buy rating and new $50 price target.

Ctrip.com International (CTRP) estimates lowered at Oppenheimer through 2013, Oppenheimer said. Impact of the PRC withholding tax. Outperform rating.

Discover Financial Services (DFS) numbers raised at Citigroup. Shares of DFS now seen reaching $35, Citigroup said. Estimates also increased to reflect better card credit. Neutral rating.

Equifax (EFX) estimates, target raised at Credit Suisse. Shares of EFX now seen reaching $50, according to Credit Suisse. Estimates also increased, as the company can likely sustain solid organic sales growth, despite difficult macro conditions. Neutral rating.

Edward Lifesciences (EW) target raised at Jefferies. Shares of EW now seen reaching $100, Jefferies said. Positive panel paves way for Sapien Label expansion. Buy rating.

Edwards Lifesciences target boosted at BMO. Shares of EW now seen reaching $94, according to BMO Capital. FDA panel was strongly in favor of approving Cohort A. Market Perform rating.

Jabil Circuit (JBL) numbers cut at Citigroup. Shares of JBL now seen reaching $21, Citigroup said. Estimates also lowered given disappointing outlooks from major customers. Neutral rating.

JC Penney (JCP) target cut at Morgan Stanley to $22, according to Morgan Stanley. Survey suggests a weaker consumer pricing environment. Underweight rating.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs